Recombinant CD40 antibody
Quick Overview for Recombinant CD40 antibody (ABIN7487699)
Target
See all CD40 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
- 
    
- 
                                            
Purpose
 - Anti-CD40 [FGK45], Rabbit IgG, kappa
 - 
                                            
Specificity
 - This antibody recognizes CD40. It is a type I transmembrane glycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD40 is expressed broadly on antigen-presenting cells (APCs) such as dendritic cells, B cells, macrophages, and monocytes as well as non-immune endothelial cells, basal epithelial cells, and a range of tumors. Upon binding to its ligand CD154, CD40 acts as a costimulatory molecule for the activation of B cells, dendritic cells, monocytes, and other APCs.
 - 
                                            
Characteristics
 - 
                        
Original Species of Ab: Rat
Original Format of Ab: IgG2a
 - 
                                            
Purification
 - Protein A affinity purified
 - 
                                            
Immunogen
 - The original rat IgG2a antibody was raised against the recombinant mouse CD40 fusion protein.
 - 
                                            
Isotype
 - IgG kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - FGK45 is an agonistic antibody that has been shown to activate CD40 expressing antigen presenting cells (APCs) what might promote anti-tumor T cell responses. For instance, the rat IgG2a version of this antibody was used to promote maturation of APCs what improved the ability of the macrophages to fight a tumour (Luheshi et al., 2016, pmid: 26918344). Another group used the same antibody to stimulate T-cells in a study on a tumor vaccine (Bartkowiak et al., 2015, pmid: 26351680). Others used ths clone as well to induce potent anti-tumor activity (Carmi et al., 2015, pmid: 25924063). On the other hand, it can also be used to inhibit CD40/CD154 interaction in vitro and in vivo. Furthermore, this clone can be also utilized to identify CD40-positive cells by flow cytometry (Rolink et al., 1996, pmid: 8885865). Administering this antibody can be also utilized to induce inflamatory bowel disease-like characteristics and create a mouse IBD model to study this class of diseases (Bauche et al., 2018, pmid: 30097293).
 - 
                                            
Comment
 - 
                        
This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Concentration
 - 1 mg/mL
 - 
                                            
Buffer
 - PBS with 0.02 % Proclin 300.
 - 
                                            
Preservative
 - ProClin
 - 
                                            
Precaution of Use
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
 
 - 
                                            
 - 
    
- CD40
 - 
                                            
Alternative Name
 - CD40
 - 
                                            
Background
 - Tnfrsf5, Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, FGK4.5
 - 
                                            
UniProt
 - P27512
 - 
                                            
Pathways
 - NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
 
Target
 -